Cerebrospinal fluid and plasma concentrations of dipyrone metabolites after a single oral dose of dipyrone

European Journal of Clinical Pharmacology

Volumn 54, Issue 7, 1998, Pages 549-553

  Cohen, O ^a   Zylber Katz, E ^a   Caraco, Y ^a   Granit, L ^a   Levy, M ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Cerebrospinal fluid; Dipyrone

Indexed keywords

4 ACETYLAMINOANTIPYRINE; 4 AMINOPHENAZONE; 4 FORMYLAMINOANTIPYRINE; DIPYRONE; DRUG METABOLITE; NORAMIDOPYRINE; PHENAZONE DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANTIPYRETIC ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG MECHANISM; DRUG METABOLISM; HUMAN; LUMBAR PUNCTURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; AGED; AMINOPYRINE; AMPYRONE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLOOD-BRAIN BARRIER; DIPYRONE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PYRAZOLONES; SPINAL PUNCTURE;

EID: 0031735556     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050511     Document Type: Article

References (26)

1. Levy M, Zylber-Katz E, Rosenkranz B (1995) Clinical pharmacokinetics of dipyrone and its metabolites. Clin Pharmacokinet 28: 216-234
2. Rohdewald P, Drehsen G, Milsmann E, Derendorf H (1993) Relationship between saliva levels of metamizol metabolites, bioavailability and analgesic efficacy. Arzneimittelforschung 33: 985-988
3. Eldor A, Zylber-Katz E, Levy M (1984) The effect of oral administration of dipyrone on the capacity of blood platelets to synthesize thromboxane A2 in man. Eur J Clin Pharmacol 26: 171-176
4. Geisslinger G, Peskar BA, Pallapies D, Sittl R, Levy M, Brune K (1996) The effect on platelet aggregation and prostanoid biosynthesis of two patenteral analgesics: ketorolac thromethamine and dipyrone. Thromb Haemost 76: 592-597
5. Peskar BM, Kleine A, Pyras F, Muller MK (1986) Gastrointestinal toxicity: role of prostaglandins and leukotrienes. Med Toxicol 1[Suppl 1]: 39-43
6. Dembinska-Kiec A, Zmuda A, Krupinska J (1976) Inhibition of prostaglandin synthetase by aspirin-like drugs in different microsomal preparations. In: Samuelsson B, Paoletti R (eds) Advances in prostaglandin and thromboxane research. Raven Press, New York, pp 99-103
7. Neugebauer V, Schaible M-G, He X, Lucke T, Gundling P, Schmidt RF (1994) Electrophysiological evidence for a spinal antiociceptive action of dipyrone. Agents Actions 41: 62-70
8. Zylber-Katz E, Granit L, Drayer DE, Levy M (1984) Simultaneous determination of dipyrone metabolites in plasma by high-performance liquid chromatography. J Chromatogr Biomed Sci Appl 305: 477-484
9. Bannwarth B, Netter P, Lapicque F, Pere P, Thomas P, Gaucher A (1990) Plasma and CSF concentrations of indomethacin in humans. Eur J Clin Pharmacol 38: 343-346
10. Bannwarth B, Netter P, Lapicque F, Gillet P, Pere P, Boccard E, Rover RJ, Gaucher A (1992) Plasma and CSF concentration of paracetamol after a single intravenous dose of paracetamol. Br J Clin Pharmacol 34: 79-81
11. Bannwarth B, Lapicque F, Pehourcq F, Gillet P, Schaeverbeke T, Laborde C, Dehais J, Gaucher A, Netter P (1995) Stereoselective disposition of ibuprofen enantiomers in human CSF. Br J Clin Pharmacol 40: 266-269
12. Bonati M, Kanto J, Tognoni G (1982) Clinical pharmacokinetics of cerebrospinal fluid. Clin Pharmacokinet 7: 312-335
13. Nau R, Zysk G, Thief A, Prang HW (1993) Pharmacokinetic quantification of the exchange of drugs between blood and CSF in man. Eur J Clin Pharmacol 45: 469-475
14. Soto J, Squeristam JA, Alsar MJ (1994) Cerebrospinal fluid concentration of caffeine following oral drug administration: correlation with salivary and plasma concentrations. Ther Drug Monit 16: 108-110
15. Somani SM, Khanna NN, Bada SB (1980) Caffeine and theophylline: serum CSF correlation in premature infants. J Pediatr 96: 1091-1093
16. Sauernheimer C, Williams KM, Brune K, Geisslinger G (1994) Application of microdialysis to the pharmacokinetics of analgesics: problems with reduction of dialysis efficiency in vivo. J Pharmacol Toxicol Methods 32: 149-154
17. Ochs HR, Greenblatt DJ, Abernethy DR, Arendt RM, Gerloff J, Fichelkraut W, Hahn N (1985) CSF uptake and peripheral distribution of centrally acting drugs: relation to lipid solubility. J Pharm Pharmacol 37: 428-431
18. Cohen EN (1963) Blood-brain barrier to D-tubocurarine. J Pharmacol Exp Ther 141: 356-362
19. Schiliep G, Rupic N, Felgenhauwer K (1974) Quantitation of high molecular proteins in cerebrospinal fluid. Z Klin Chem Klin Bioch 12: 367-369
20. Ghersi-Egla J-F, Perrin R, Leninger-Muller B, Grassiot MC, Jeandel C, Floquet J, Cuny G, Siest G, Minn A (1993) Subcellular localization of xytochrome P450, and activities of several enzymes responsible for drug metabolism in the human brain. Biochem Pharmacol 45: 647-658
21. Geisslinger G, Bocker R, Levy M (1996) High-performance liquid chromatographic analysis of dipyrone metabolites to study their formation in human liver microsomes. Pharm Res 13: 1272-1275
22. Caraco Y, Zylber-Katz E, Granit L, Levy M (1993) Validity of saliva samples for the estimation of dipyrone metabolites pharmacokinetics. Arzneimittelforschung 43: 1204-1208
23. Zylber-Katz E, Linder N, Granit L, Levy M (1986) Excretion of dipyrone metabolites in human breast milk. Eur J Clin Pharmacol 30: 359-361
24. Zylber-Katz E, Levy M, Granit L (1985) Plasma protein binding of dipyrone metabolites in man. Eur J Clin Pharmacol 29: 67-71
25. Welch RM, DeAngelis RL, Wingfield M, Farmer TW (1975) Elimination of antipyrine from saliva as a measure of metabolism in man. Clin Pharmacol Ther 18: 249-258
26. Kamali F, Fry JR, Bell GO (1987) Salivary secretion of paracetamol in man. J Pharm Pharmacol 39: 150-152